Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| STAT5A | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 2.39E5 | Evidence |
O
|
||||
| STAT5A | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 1.37E5 | Evidence |
|
||||
| STAT5A | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 1.28E5 | Evidence | |||||
| STAT5A | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 1.18E5 | Evidence | |||||
| STAT5A | KIT | KIT: Mast/stem cell growth factor receptor precursor | 1.11E5 | Evidence |
|
||||
| STAT5A | CRKL | CRKL: Crk-like protein | 9.84E4 | Evidence |
O
|
||||
| STAT5A | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 9.37E4 | Evidence |
O
|
||||
| STAT5A | INSR | INSR: Insulin receptor precursor | 6.35E4 | Evidence |
|
||||
| STAT5A | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 5.72E4 | Evidence |
|
||||
| STAT5A | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 3.37E4 | Evidence | |||||
| STAT5A | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 3.01E4 | Evidence |
|
||||
| STAT5A | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 2.58E4 | Evidence |
|
||||
| STAT5A | CREBBP | CREBBP, CBP: CREB-binding protein | 1.07E4 | Evidence | |||||
| STAT5A | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.02E4 | Evidence |
|
||||
| STAT5A | GRAP | GRAP: GRB2-related adapter protein | 7.29E3 | Evidence | |||||
| STAT5A | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 6.59E3 | Evidence | |||||
| STAT5A | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 6.01E3 | Evidence | |||||
| STAT5A | STAT3 | 2.89E3 | Evidence |
|
|||||
| STAT5A | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.27E3 | Evidence | |||||
| STAT5A | MAP2K3 | N/A | 1.67E3 | Evidence | |||||
| STAT5A | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.01E3 | Evidence | |||||
| STAT5A | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 835.0 | Evidence | |||||
| STAT5A | SHC4 | SHC-transforming protein 4 | 591.0 | Evidence | |||||
| STAT5A | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 555.0 | Evidence |
|
||||
| STAT5A | SYK | SYK: Tyrosine-protein kinase SYK | 497.0 | Evidence |
|
||||
| STAT5A | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 497.0 | Evidence |
|
||||
| STAT5A | JAK1 | 407.0 | Evidence |
O
|
|||||
| STAT5A | LYN | LYN: Tyrosine-protein kinase Lyn | 407.0 | Evidence | |||||
| STAT5A | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 407.0 | Evidence | |||||
| STAT5A | HCK | N/A | 407.0 | Evidence | |||||
| STAT5A | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 345.0 | Evidence | |||||
| STAT5A | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 325.0 | Evidence | |||||
| STAT5A | CSK | CSK: Tyrosine-protein kinase CSK | 301.0 | Evidence | |||||
| STAT5A | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 275.0 | Evidence |
|
||||
| STAT5A | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 268.0 | Evidence | |||||
| STAT5A | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 200.0 | Evidence |
|
||||
| STAT5A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
| STAT5A | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 177.0 | Evidence |
|
||||
| STAT5A | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 158.0 | Evidence | |||||
| STAT5A | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 135.0 | Evidence | |||||
| STAT5A | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 135.0 | Evidence | |||||
| STAT5A | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 132.0 | Evidence |
|
||||
| STAT5A | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 132.0 | Evidence | |||||
| STAT5A | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 119.0 | Evidence | |||||
| STAT5A | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 119.0 | Evidence | |||||
| STAT5A | BMX | N/A | 107.0 | Evidence |
|
||||
| STAT5A | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 107.0 | Evidence | |||||
| STAT5A | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| STAT5A | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 105.0 | Evidence | |||||
| STAT5A | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 104.0 | Evidence | |||||
| STAT5A | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 90.80 | Evidence | |||||
| STAT5A | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 90.80 | Evidence | |||||
| STAT5A | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 85.20 | Evidence | |||||
| STAT5A | DOK1 | DOK1: Docking protein 1 | 85.20 | Evidence | |||||
| STAT5A | CD2AP | CD2AP: CD2-associated protein | 85.20 | Evidence | |||||
| STAT5A | VAV1 | VAV1, VAV: Proto-oncogene vav | 85.20 | Evidence | |||||
| STAT5A | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 85.20 | Evidence | |||||
| STAT5A | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 81.20 | Evidence | |||||
| STAT5A | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 79.90 | Evidence | |||||
| STAT5A | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 70.10 | Evidence | |||||
| STAT5A | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 65.30 | Evidence | |||||
| STAT5A | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 62.90 | Evidence | |||||
| STAT5A | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 62.90 | Evidence | |||||
| STAT5A | WASPIP | N/A | 62.90 | Evidence | |||||
| STAT5A | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 62.90 | Evidence | |||||
| STAT5A | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 57.70 | Evidence | |||||
| STAT5A | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 51.60 | Evidence | |||||
| STAT5A | LCP1 | LCP1, PLS2: Plastin-2 | 51.60 | Evidence | |||||
| STAT5A | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 51.50 | Evidence | |||||
| STAT5A | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 51.50 | Evidence | |||||
| STAT5A | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 51.50 | Evidence | |||||
| STAT5A | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 51.50 | Evidence | |||||
| STAT5A | MET | MET: Hepatocyte growth factor receptor precursor | 47.20 | Evidence | |||||
| STAT5A | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 46.30 | Evidence | |||||
| STAT5A | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 46.30 | Evidence | |||||
| STAT5A | PPP2CB | PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 44.20 | Evidence | |||||
| STAT5A | IRS2 | IRS2: Insulin receptor substrate 2 | 43.60 | Evidence | |||||
| STAT5A | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 43.60 | Evidence | |||||
| STAT5A | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 42.6 | Evidence | |||||
| STAT5A | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 39.10 | Evidence | |||||
| STAT5A | NCK2 | NCK2: Cytoplasmic protein NCK2 | 39.10 | Evidence | |||||
| STAT5A | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 38.10 | Evidence | |||||
| STAT5A | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 38.10 | Evidence | |||||
| STAT5A | CCR5 | CCR5: CCR5 receptor (Fragment) | 37.90 | Evidence |
|
||||
| STAT5A | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 37.90 | Evidence | |||||
| STAT5A | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 37.90 | Evidence | |||||
| STAT5A | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 37.90 | Evidence | |||||
| STAT5A | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 37.80 | Evidence | |||||
| STAT5A | LNK | SH2B3, LNK: SH2B adapter protein 3 | 37.80 | Evidence | |||||
| STAT5A | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 37.80 | Evidence | |||||
| STAT5A | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 34.80 | Evidence | |||||
| STAT5A | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 34.80 | Evidence | |||||
| STAT5A | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 33.90 | Evidence | |||||
| STAT5A | SOS1 | SOS1: Son of sevenless homolog 1 | 33.90 | Evidence | |||||
| STAT5A | ACTN4 | ACTN4: Alpha-actinin-4 | 33.90 | Evidence | |||||
| STAT5A | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 33.90 | Evidence | |||||
| STAT5A | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 33.90 | Evidence | |||||
| STAT5A | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 33.90 | Evidence | |||||
| STAT5A | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 33.90 | Evidence | |||||
| STAT5A | CDK2 | CDK2: Cell division protein kinase 2 | 32.80 | Evidence | |||||
| STAT5A | STYK1 | STYK1, NOK: Tyrosine protein-kinase STYK1 | 32.70 | Evidence | |||||
| STAT5A | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 31.70 | Evidence | |||||
| STAT5A | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 31.20 | Evidence |
O
|
||||
| STAT5A | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 31.20 | Evidence | |||||
| STAT5A | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 31.20 | Evidence | |||||
| STAT5A | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 31.20 | Evidence | |||||
| STAT5A | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 28.70 | Evidence | |||||
| STAT5A | ETS2 | ETS2: Protein C-ets-2 | 28.70 | Evidence | |||||
| STAT5A | H1FX | H1FX: Histone H1x | 28.30 | Evidence | |||||
| STAT5A | GAB1 | GAB1: GRB2-associated-binding protein 1 | 28.20 | Evidence | |||||
| STAT5A | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 28.00 | Evidence | |||||
| STAT5A | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 27.90 | Evidence | |||||
| STAT5A | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 27.90 | Evidence | |||||
| STAT5A | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 26.80 | Evidence | |||||
| STAT5A | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 26.40 | Evidence | |||||
| STAT5A | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 26.40 | Evidence | |||||
| STAT5A | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 26.00 | Evidence | |||||
| STAT5A | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 26.00 | Evidence | |||||
| STAT5A | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 26.00 | Evidence |
|
||||
| STAT5A | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 25.70 | Evidence |
|
||||
| STAT5A | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 25.30 | Evidence | |||||
| STAT5A | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 25.30 | Evidence | |||||
| STAT5A | STAM2 | STAM2: Signal transducing adapter molecule 2 | 25.3 | Evidence | |||||
| STAT5A | DAB1 | DAB1: Disabled homolog 1 | 25.3 | Evidence | |||||
| STAT5A | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 25.3 | Evidence | |||||
| STAT5A | APS | SH2B2, APS: SH2B adapter protein 2 | 25.3 | Evidence | |||||
| STAT5A | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 24.90 | Evidence | |||||
| STAT5A | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 24.90 | Evidence | |||||
| STAT5A | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 24.90 | Evidence | |||||
| STAT5A | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 24.90 | Evidence | |||||
| STAT5A | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 24.90 | Evidence |
|
||||
| STAT5A | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 24.90 | Evidence | |||||
| STAT5A | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 24.90 | Evidence | |||||
| STAT5A | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 24.90 | Evidence | |||||
| STAT5A | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 24.80 | Evidence | |||||
| STAT5A | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 23.70 | Evidence | |||||
| STAT5A | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 23.70 | Evidence | |||||
| STAT5A | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 23.70 | Evidence | |||||
| STAT5A | EPOR | EPOR: Erythropoietin receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | GHR | GHR: Growth hormone receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 22.90 | Evidence | |||||
| STAT5A | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 22.90 | Evidence | |||||
| STAT5A | AMPH | AMPH, AMPH1: Amphiphysin | 22.90 | Evidence | |||||
| STAT5A | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 22.80 | Evidence | |||||
| STAT5A | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 22.60 | Evidence | |||||
| STAT5A | IRS1 | IRS1: Insulin receptor substrate 1 | 22.40 | Evidence | |||||
| STAT5A | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 22.30 | Evidence | |||||
| STAT5A | L1CAM | L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor | 22.30 | Evidence | |||||
| STAT5A | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 22.20 | Evidence | |||||
| STAT5A | DYRK3 | N/A | 22.20 | Evidence | |||||
| STAT5A | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 22.20 | Evidence | |||||
| STAT5A | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 21.40 | Evidence | |||||
| STAT5A | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 20.6 | Evidence | |||||
| STAT5A | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 20.6 | Evidence | |||||
| STAT5A | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 20.50 | Evidence | |||||
| STAT5A | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 20.50 | Evidence | |||||
| STAT5A | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 20.50 | Evidence | |||||
| STAT5A | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 20.50 | Evidence | |||||
| STAT5A | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 20.50 | Evidence | |||||
| STAT5A | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
| STAT5A | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 20.10 | Evidence | |||||
| STAT5A | MYO3A | MYO3A: Myosin IIIA | 20.00 | Evidence | |||||
| STAT5A | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.00 | Evidence | |||||
| STAT5A | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 19.20 | Evidence | |||||
| STAT5A | NMI | NMI: N-myc-interactor | 19.00 | Evidence |
O
|
||||
| STAT5A | CDK5 | CDK5: Cell division protein kinase 5 | 18.90 | Evidence | |||||
| STAT5A | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 18.60 | Evidence |
O
|
||||
| STAT5A | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 18.60 | Evidence | |||||
| STAT5A | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 18.60 | Evidence | |||||
| STAT5A | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 18.60 | Evidence | |||||
| STAT5A | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 18.40 | Evidence | |||||
| STAT5A | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
| STAT5A | CDC2 | CDC2: Cell division control protein 2 homolog | 17.60 | Evidence | |||||
| STAT5A | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 17.50 | Evidence | |||||
| STAT5A | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 17.40 | Evidence | |||||
| STAT5A | LOC389305 | Uncharacterized protein ENSP00000349185 (Fragment) | 17.40 | Evidence | |||||
| STAT5A | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 17.10 | Evidence | |||||
| STAT5A | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 16.40 | Evidence | |||||
| STAT5A | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 16.40 | Evidence | |||||
| STAT5A | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 16.30 | Evidence | |||||
| STAT5A | HDAC3 | HDAC3: Histone deacetylase 3 | 15.30 | Evidence | |||||
| STAT5A | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 15.30 | Evidence | |||||
| STAT5A | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 15.30 | Evidence | |||||
| STAT5A | VCAM1 | VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor | 15.10 | Evidence | |||||
| STAT5A | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 15.10 | Evidence | |||||
| STAT5A | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 15.10 | Evidence | |||||
| STAT5A | ALCAM | ALCAM, MEMD: CD166 antigen precursor | 14.70 | Evidence | |||||
| STAT5A | PRLR | PRLR: Prolactin receptor precursor | 14.70 | Evidence | |||||
| STAT5A | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 14.70 | Evidence | |||||
| STAT5A | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 14.60 | Evidence |
|
||||
| STAT5A | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 14.40 | Evidence | |||||
| STAT5A | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 14.40 | Evidence | |||||
| STAT5A | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 14.10 | Evidence | |||||
| STAT5A | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.90 | Evidence | |||||
| STAT5A | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 13.80 | Evidence | |||||
| STAT5A | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 13.70 | Evidence | |||||
| STAT5A | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 13.70 | Evidence | |||||
| STAT5A | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 13.70 | Evidence | |||||
| STAT5A | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 13.50 | Evidence | |||||
| STAT5A | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 13.50 | Evidence | |||||
| STAT5A | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 13.50 | Evidence | |||||
| STAT5A | SORBS3 | SORBS3, SCAM1: Vinexin | 13.50 | Evidence | |||||
| STAT5A | DAB2 | DAB2, DOC2: Disabled homolog 2 | 13.50 | Evidence | |||||
| STAT5A | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 13.40 | Evidence | |||||
| STAT5A | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 13.20 | Evidence | |||||
| STAT5A | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 13.00 | Evidence | |||||
| STAT5A | MCM3 | MCM3: DNA replication licensing factor MCM3 | 12.50 | Evidence | |||||
| STAT5A | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 12.40 | Evidence | |||||
| STAT5A | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 12.10 | Evidence | |||||
| STAT5A | CHUK | N/A | 11.80 | Evidence | |||||
| STAT5A | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 11.80 | Evidence | |||||
| STAT5A | LOC649805 | Ig heavy chain V-II region COR | 11.70 | Evidence | |||||
| STAT5A | CRK | CRK: Proto-oncogene C-crk | 11.70 | Evidence |
|
||||
| STAT5A | GRB10 | N/A | 11.70 | Evidence | |||||
| STAT5A | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 11.60 | Evidence | |||||
| STAT5A | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 11.50 | Evidence | |||||
| STAT5A | JUND | JUND: Transcription factor jun-D | 11.30 | Evidence | |||||
| STAT5A | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 11.30 | Evidence | |||||
| STAT5A | OSTF1 | N/A | 11.30 | Evidence | |||||
| STAT5A | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 11.30 | Evidence | |||||
| STAT5A | S100A3 | S100A3, S100E: Protein S100-A3 | 11.30 | Evidence | |||||
| STAT5A | S100B | S100B: Protein S100-B | 11.30 | Evidence | |||||
| STAT5A | PHB2 | PHB2, BAP, REA: Prohibitin-2 | 11.00 | Evidence | |||||
| STAT5A | PARVA | PARVA, MXRA2: Alpha-parvin | 10.80 | Evidence | |||||
| STAT5A | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 10.70 | Evidence | |||||
| STAT5A | RP2 | RP2: Protein XRP2 | 10.60 | Evidence | |||||
| STAT5A | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 10.60 | Evidence | |||||
| STAT5A | SYNGAP1 | SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP | 10.50 | Evidence | |||||
| STAT5A | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 10.50 | Evidence | |||||
| STAT5A | INSRR | INSRR, IRR: Insulin receptor-related protein precursor | 10.50 | Evidence | |||||
| STAT5A | FADD | FADD, MORT1: Protein FADD | 10.30 | Evidence | |||||
| STAT5A | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 10.30 | Evidence |
|
||||
| STAT5A | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 10.30 | Evidence | |||||
| STAT5A | HSP90AA1 | Hsp89-alpha-delta-N | 10.30 | Evidence | |||||
| STAT5A | EPRS | EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: | 10.30 | Evidence | |||||
| STAT5A | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 10.30 | Evidence | |||||
| STAT5A | FLNB | FLNB, FLN1L, FLN3, TABP, TAP: Filamin-B | 10.00 | Evidence | |||||
| STAT5A | CEACAM1 | CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr | 9.94 | Evidence | |||||
| STAT5A | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
| STAT5A | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 9.73 | Evidence | |||||
| STAT5A | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 9.55 | Evidence | |||||
| STAT5A | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 9.33 | Evidence | |||||
| STAT5A | RELA | RELA, NFKB3: Transcription factor p65 | 9.29 | Evidence | |||||
| STAT5A | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 9.29 | Evidence | |||||
| STAT5A | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 9.29 | Evidence |
O
|
||||
| STAT5A | NCF2 | NCF2: Neutrophil cytosol factor 2 | 9.29 | Evidence | |||||
| STAT5A | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 8.96 | Evidence | |||||
| STAT5A | IL10RB | IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor | 8.92 | Evidence | |||||
| STAT5A | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 8.90 | Evidence | |||||
| STAT5A | S100A9 | S100A9, CAGB, CFAG, MRP14: Protein S100-A9 | 8.76 | Evidence | |||||
| STAT5A | KPNB1 | KPNB1, NTF97: Importin subunit beta-1 | 8.74 | Evidence | |||||
| STAT5A | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 8.72 | Evidence | |||||
| STAT5A | VCP | VCP: Transitional endoplasmic reticulum ATPase | 8.72 | Evidence | |||||
| STAT5A | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 8.72 | Evidence | |||||
| STAT5A | EVL | N/A | 8.72 | Evidence | |||||
| STAT5A | PTPN11 | N/A | 8.72 | Evidence |
|
||||
| STAT5A | CD44 | N/A | 8.44 | Evidence | |||||
| STAT5A | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 8.35 | Evidence | |||||
| STAT5A | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 8.00 | Evidence | |||||
| STAT5A | TP53 | TP53, P53: Cellular tumor antigen p53 | 8.00 | Evidence | |||||
| STAT5A | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 7.99 | Evidence | |||||
| STAT5A | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 7.99 | Evidence | |||||
| STAT5A | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 7.73 | Evidence | |||||
| STAT5A | MAL2 | MAL2: Protein MAL2 | 7.72 | Evidence | |||||
| STAT5A | HDAC2 | HDAC2: Histone deacetylase 2 | 7.45 | Evidence | |||||
| STAT5A | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 7.40 | Evidence | |||||
| STAT5A | KCNJ3 | KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 | 7.40 | Evidence | |||||
| STAT5A | UNG | N/A | 7.38 | Evidence | |||||
| STAT5A | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 7.38 | Evidence | |||||
| STAT5A | PAPOLA | PAPOLA, PAP: Poly(A) polymerase alpha | 7.38 | Evidence | |||||
| STAT5A | MAP3K9 | MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 | 7.14 | Evidence | |||||
| STAT5A | MARK2 | N/A | 7.14 | Evidence | |||||
| STAT5A | PTPRA | N/A | 7.14 | Evidence | |||||
| STAT5A | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 7.05 | Evidence | |||||
| STAT5A | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 7.05 | Evidence |
O
|
||||
| STAT5A | JUN | JUN: Transcription factor AP-1 | 7.05 | Evidence | |||||
| STAT5A | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 6.98 | Evidence |
|
||||
| STAT5A | FOXM1 | FOXM1, FKHL16, HFH11, MPP2, WIN: Forkhead box protein M1 | 6.82 | Evidence | |||||
| STAT5A | EDNRB | EDNRB, ETRB: Endothelin B receptor precursor | 6.82 | Evidence | |||||
| STAT5A | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 6.65 | Evidence | |||||
| STAT5A | TSHR | N/A | 6.63 | Evidence | |||||
| STAT5A | AKR7A2 | AKR7A2, AFAR, AFAR1, AKR7: Aflatoxin B1 aldehyde reductase member 2 | 6.62 | Evidence | |||||
| STAT5A | SOS2 | SOS2: Son of sevenless homolog 2 | 6.54 | Evidence | |||||
| STAT5A | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 6.45 | Evidence | |||||
| STAT5A | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 6.40 | Evidence | |||||
| STAT5A | STAP2 | Uncharacterized protein ENSP00000317912 | 6.40 | Evidence |
|
||||
| STAT5A | PRKCH | PRKCH, PKCL, PRKCL: Protein kinase C eta type | 6.31 | Evidence | |||||
| STAT5A | MAP4K5 | MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 | 6.31 | Evidence | |||||
| STAT5A | SOCS2 | SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 | 6.31 | Evidence | |||||
| STAT5A | IL6R | IL6R: Interleukin-6 receptor alpha chain precursor | 6.26 | Evidence | |||||
| STAT5A | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 6.11 | Evidence | |||||
| STAT5A | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 6.11 | Evidence | |||||
| STAT5A | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 6.11 | Evidence | |||||
| STAT5A | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 6.11 | Evidence | |||||
| STAT5A | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 6.11 | Evidence | |||||
| STAT5A | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 5.99 | Evidence | |||||
| STAT5A | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 5.97 | Evidence | |||||
| STAT5A | KCNJ12 | KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 | 5.97 | Evidence | |||||
| STAT5A | BCR | N/A | 5.73 | Evidence | |||||
| STAT5A | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 5.73 | Evidence | |||||
| STAT5A | IGFBP5 | IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor | 5.66 | Evidence | |||||
| STAT5A | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 5.63 | Evidence | |||||
| STAT5A | THBS3 | THBS3, TSP3: Thrombospondin-3 precursor | 5.62 | Evidence | |||||
| STAT5A | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 5.54 | Evidence | |||||
| STAT5A | KPNA5 | KPNA5: Importin subunit alpha-6 | 5.46 | Evidence | |||||
| STAT5A | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 5.45 | Evidence | |||||
| STAT5A | TNNC1 | TNNC1, TNNC: Troponin C, slow skeletal and cardiac muscles | 5.41 | Evidence | |||||
| STAT5A | IRF1 | IRF1: Interferon regulatory factor 1 | 5.40 | Evidence | |||||
| STAT5A | FGFR2 | N/A | 5.34 | Evidence | |||||
| STAT5A | COPA | COPA: Coatomer subunit alpha | 5.28 | Evidence | |||||
| STAT5A | TNC | TNC, HXB: Tenascin precursor | 5.27 | Evidence | |||||
| STAT5A | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 5.11 | Evidence | |||||
| STAT5A | VAV3 | VAV3: Protein vav-3 | 5.04 | Evidence | |||||
| STAT5A | GNB2L1 | Lung cancer oncogene 7 | 4.99 | Evidence | |||||
| STAT5A | TOP2B | N/A | 4.99 | Evidence | |||||
| STAT5A | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 4.85 | Evidence | |||||
| STAT5A | C20orf75 | C20orf75: Uncharacterized protein C20orf75 precursor | 4.80 | Evidence | |||||
| STAT5A | KIR2DL3 | KIR2DL3, CD158B2, KIRCL23, NKAT2: Killer cell immunoglobulin-like receptor 2DL3 | 4.80 | Evidence | |||||
| STAT5A | TRPV3 | TRPV3: Transient receptor potential cation channel subfamily V member 3 | 4.80 | Evidence | |||||
| STAT5A | CD200R1 | CD200R1, CD200R, CRTR2, MOX2R, OX2R: Cell surface glycoprotein OX2 receptor prec | 4.80 | Evidence | |||||
| STAT5A | FRS2 | FRS2: Fibroblast growth factor receptor substrate 2 | 4.77 | Evidence | |||||
| STAT5A | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 4.58 | Evidence | |||||
| STAT5A | VDR | VDR, NR1I1: Vitamin D3 receptor | 4.58 | Evidence | |||||
| STAT5A | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 4.58 | Evidence | |||||
| STAT5A | TRHR | TRHR: Thyrotropin-releasing hormone receptor | 4.56 | Evidence | |||||
| STAT5A | COPE | COPE: Coatomer subunit epsilon | 4.55 | Evidence | |||||
| STAT5A | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 4.51 | Evidence | |||||
| STAT5A | EP300 | N/A | 4.47 | Evidence |
|
||||
| STAT5A | NUP153 | N/A | 4.47 | Evidence | |||||
| STAT5A | RNF31 | ISGF3G, IRF9: Transcriptional regulator ISGF3 subunit gamma | 4.42 | Evidence | |||||
| STAT5A | IRF2 | IRF2: Interferon regulatory factor 2 | 4.42 | Evidence | |||||
| STAT5A | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 4.42 | Evidence | |||||
| STAT5A | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 4.30 | Evidence | |||||
| STAT5A | CRK | N/A | 4.28 | Evidence |
|
||||
| STAT5A | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 4.28 | Evidence |
|
||||
| STAT5A | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 4.08 | Evidence | |||||
| STAT5A | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 4.07 | Evidence | |||||
| STAT5A | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 4.04 | Evidence | |||||
| STAT5A | CHGB | CHGB, SCG1: Secretogranin-1 precursor | 4.04 | Evidence | |||||
| STAT5A | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 4.02 | Evidence | |||||
| STAT5A | STMN1 | STMN1, LAP18, OP18: Stathmin | 4.01 | Evidence | |||||
| STAT5A | SUPT5H | SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 | 4.00 | Evidence | |||||
| STAT5A | CASP9 | CASP9, MCH6: Caspase-9 precursor | 3.88 | Evidence | |||||
| STAT5A | PTPN7 | N/A | 3.88 | Evidence | |||||
| STAT5A | DAPP1 | N/A | 3.87 | Evidence | |||||
| STAT5A | VIL1 | VIL1, VIL: Villin-1 | 3.77 | Evidence | |||||
| STAT5A | GMFB | GMFB: Glia maturation factor beta | 3.77 | Evidence | |||||
| STAT5A | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
| STAT5A | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
| STAT5A | SCARB2 | SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 | 3.62 | Evidence | |||||
| STAT5A | SOCS5 | SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 | 3.62 | Evidence | |||||
| STAT5A | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 3.62 | Evidence | |||||
| STAT5A | PIAS1 | PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 | 3.58 | Evidence | |||||
| STAT5A | KPNA6 | N/A | 3.52 | Evidence | |||||
| STAT5A | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 3.41 | Evidence | |||||
| STAT5A | POLR2A | POLR2A: Uncharacterized protein POLR2A | 3.39 | Evidence | |||||
| STAT5A | ITGAV | ITGAV, MSK8, VNRA: Integrin alpha-V precursor | 3.31 | Evidence | |||||
| STAT5A | ITGA2B | ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor | 3.30 | Evidence | |||||
| STAT5A | OPTC | OPTC, OPT: Opticin precursor | 3.28 | Evidence | |||||
| STAT5A | PCDHA2 | PCDHA2: Protocadherin alpha 2 precursor | 3.28 | Evidence | |||||
| STAT5A | CHN2 | CHN2, ARHGAP3, BCH: Beta-chimaerin | 3.24 | Evidence | |||||
| STAT5A | POU2F1 | POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 | 3.02 | Evidence |
|
||||
| STAT5A | HNRPM | HNRPM, NAGR1: Heterogeneous nuclear ribonucleoprotein M | 2.93 | Evidence | |||||
| STAT5A | NUP98 | N/A | 2.93 | Evidence | |||||
| STAT5A | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 2.93 | Evidence | |||||
| STAT5A | HLA-DQA1 | HLA-DQA2, HLA-DXA: HLA class II histocompatibility antigen, DQ(6) alpha chain pr | 2.91 | Evidence | |||||
| STAT5A | CRLF2 | CRLF2, ILXR, TSLPR: Cytokine receptor-like factor 2 precursor | 2.91 | Evidence | |||||
| STAT5A | BTLA | BTLA: B- and T-lymphocyte attenuator precursor | 2.91 | Evidence | |||||
| STAT5A | SCN4B | SCN4B: Sodium channel beta-4 subunit precursor | 2.91 | Evidence | |||||
| STAT5A | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 2.83 | Evidence |
|
||||
| STAT5A | GGCX | GGCX, GC: Vitamin K-dependent gamma-carboxylase | 2.70 | Evidence | |||||
| STAT5A | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.70 | Evidence | |||||
| STAT5A | SHC2 | N/A | 2.69 | Evidence | |||||
| STAT5A | CAV1 | CAV1, CAV: Caveolin-1 | 2.66 | Evidence | |||||
| STAT5A | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 2.59 | Evidence | |||||
| STAT5A | HPCA | HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin | 2.53 | Evidence | |||||